Rchr
J-GLOBAL ID：202301016110311496
Update date: Jan. 30, 2024
momii yasutomo
モミイ ヤストモ | momii yasutomo
Affiliation and department：
Job title：
Assistant Professor
Research theme for competitive and other funds (3)：
- 2023 - 2026 Comprehensive molecular diagnosis of glioma by liquid biopsy
- 2015 - 2018 Development of novel therapy against glioma stem cells using super catalytic antibodies.
- 2013 - 2016 Development of therapies targeting tumor stem cells,and the genetic analysis of brain tumor usig hypoxia PET.
Papers (28)：
-
Yoshihiro Muragaki, Eiichi Ishikawa, Takashi Maruyama, Masayuki Nitta, Taiichi Saito, Soko Ikuta, Takashi Komori, Takakazu Kawamata, Tetsuya Yamamoto, Koji Tsuboi, et al. A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas. Journal of neurosurgery. 2023. 1-11
-
Kouhei Onishi, Tohru Kamida, Minoru Fujiki, Yasutomo Momii, Kenji Sugita. Anticonvulsant and antioxidant effects of lamotrigine on pilocarpine-induced status epilepticus in mice. Neuroreport. 2023. 34. 1. 61-66
-
Kazuhiko Mishima, Ryo Nishikawa, Yoshitaka Narita, Junki Mizusawa, Minako Sumi, Tomoyuki Koga, Nobuyoshi Sasaki, Manabu Kinoshita, Motoo Nagane, Yoshiki Arakawa, et al. Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C. Neuro-oncology. 2022. 25. 4. 687-698
-
Kosuke Aoki, Hiromichi Suzuki, Takashi Yamamoto, Kimiyo N Yamamoto, Sachi Maeda, Yusuke Okuno, Melissa Ranjit, Kazuya Motomura, Fumiharu Ohka, Kuniaki Tanahashi, et al. Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas. Cancer research. 2021. 81. 18. 4861-4873
-
Hirotaka Fudaba, Yasutomo Momii, Hiroyuki Matsuta, Kouhei Onishi, Yukari Kawasaki, Kenji Sugita, Tsuyoshi Shimomura, Minoru Fujiki. Perfusion Parameter Obtained on 3-Tesla Magnetic Resonance Imaging and the Ki-67 Labeling Index Predict the Overall Survival of Glioblastoma. World neurosurgery. 2021. 149. e469-e480
ｍore...
MISC (8)：
-
Kazuhiko Mishima, Ryo Nishikawa, Yoshitaka Narita, Junki Mizusawa, Minako Sumi, Manabu Kinoshita, Motoo Nagane, Yoshiki Arakawa, Koji Yoshimoto, Ichiyo Shibahara, et al. Randomized phase III study of high-dose methotrexate and whole brain radiotherapy with or without concomitant and adjuvant temozolomide in patients with newly diagnosed primary central nervous system lymphoma: JCOG1114C. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
-
Hirotaka Fudaba, Yasutomo Momii, Kouhei Onishi, Takashi Hirano, Hidetaka Yamamoto, Minoru Fujiki. Recurrence of biphenotypic sinonasal sarcoma with cerebral hemorrhaging: A case report with an 11-year follow-up. BRAIN PATHOLOGY. 2019. 29. 169-169
-
Tatsuya Abe, Yukiko Nakahara, Motofumi Kouguchi, Hiroshi Ito, Tomihiro Wakamiya, Ikuko Morisaki, Yasutomo Momii, Hirotaka Fudaba, Minoru Fujiki. EXPRESSION OF DRUG RESISTANCE GENES ASSOCIATED WITH HYPOXIA IN HUMAN GLIOMA. NEURO-ONCOLOGY. 2016. 18. 52-52
-
Kosuke Aoki, Hiromichi Suzuki, Hideo Nakamura, Keitaro Matsuo, Kazuya Motomura, Fumiharu Okha, Masahiro Mizoguchi, Yasutomo Momii, Yoshihiro Muragaki, Reiko Watanabe, et al. COMPREHENSIVE MUTATIONAL AND CYTOGENETIC ANALYSIS REVEALED GENETIC PROGNOSTIC FACTORS IN GRADE II AND III GLIOMAS. NEURO-ONCOLOGY. 2016. 18. 109-109
-
Kosuke Aoki, Hiromichi Suzuki, Hideo Nakamura, Keitaro Matsuo, Kazuya Motomura, Fumiharu Ohka, Masahiro Mizoguchi, Yasutomo Momii, Yasuhiro Muragaki, Satoru Miyano, et al. Genetic subtype-specific prognostic significance of genetic alterations in lower-grade gliomas. CANCER RESEARCH. 2016. 76
ｍore...
Return to Previous Page
